Allergies News and Research

Latest Allergies News and Research

Wyeth gets approval for needle-less syringe for the treatment of hemophilia

Wyeth Pharmaceuticals has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for the ReFacto Antihemophilic Factor (Recombinant) R2 Kit, the first needle-less reconstitution device with a prefilled diluent syringe for hemophilia.

14 Sep 2004

New insights into the international burden of malaria

Malaria research scientists from around the globe have published new insights into the international burden of malaria and what can be done about it.

14 Sep 2004

First molecular-scale images of DNA binding to an adenovirus enzyme

The images, which appear on the cover of the October 2004 issue of Molecular and Cellular Proteomics, show how binding to DNA may stimulate the enzyme and are already being used to design new antiviral drugs to block this interaction.

14 Sep 2004

Schering-Plough and Bayer form strategic alliance

Schering-Plough Corporation has announced that it has entered into a strategic agreement with Bayer designed to maximize the companies' pharmaceutical resources while maintaining each company's own strategic interests.

13 Sep 2004

Program that targets allergens and tobacco smoke in the home resulted in fewer asthma symptoms in children

A program that targets allergens and tobacco smoke in the home resulted in fewer asthma symptoms in children participating in the intervention than in those who were not, according to a new study sponsored by the National Institutes of Health (NIH) in seven metropolitan areas nationwide.

10 Sep 2004

Study aims for long term impact to help inner-city children with asthma

A study designed to reduce the levels of indoor allergens – conducted in the homes of inner-city children with asthma – resulted in fewer asthma exacerbations and unscheduled visits for asthma during a two-year period, according to a UT Southwestern Medical Center at Dallas researcher who participated in the multicenter study.

8 Sep 2004

Hospitals should use latex medical gloves with lower protein and powder levels to reduce latex sensitivity rather than synthetic alternatives

The non-profit, independent evaluator of medical devices notes that while some synthetic alternatives may cost less, latex gloves are still the most cost-effective choice when a glove offering a good level of protection is required.

8 Sep 2004

Researchers uncover how HIV causes abnormalities in antibody-producing cells

HIV wreaks much of its damage by targeting the “orchestra conductor” of the immune system, a key class of T cells—CD4+ T cells—whose destructive relationship with HIV has been well-studied by AIDS researchers.

8 Sep 2004

Researchers keep milk free of contaminants

Dairy farms in the United States produced more than 170 billion pounds of milk last year. The more than 9 million cows that produced that milk occasionally need to be treated for various ailments

8 Sep 2004

Cymbalta approved for diabetic peripheral neuropathy pain

The U.S. Food and Drug Administration has approved Eli Lilly's Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor. Cymbalta is the first and only FDA-approved treatment for pain caused by diabetic peripheral neuropathy.

8 Sep 2004

Researchers unravel genetic makeup of ticks to tackle disease

Ticks as small as a freckle can transmit a number of illnesses for which there is no vaccine and, in some cases, no cure. These creatures even could become bioterrorism weapons.

4 Sep 2004

Launch of one of the US's largest electronic medical record implementations

As part of an ongoing mission to improve the quality and safety of patient care, Buffalo Hospital is the first Allina hospital to transition away from paper processes and begin using an electronic medical record system that will ultimately be shared by all of Allina’s seventy-six sites, including 11 hospitals and sixty-five clinics.

1 Sep 2004

Call for increased political and financial commitment to the development of preventive and therapeutic AIDS vaccines

At the opening ceremony of the Lausanne, Switzerland, AIDS VACCINE '04 conference, leaders in the field of AIDS vaccine research called for increased political and financial commitment to facilitate the development of preventive and therapeutic AIDS vaccines as a public health imperative in fighting HIV/AIDS.

30 Aug 2004

Environmental factors and diet may explain the higher rates of asthma seen in developed countries

The study involved 10,902 primary school children from three cities in China at different stages of modernisation (Hong Kong, Beijing and Guangzhou). Parents were asked about asthmatic symptoms and exposure to environmental factors.

26 Aug 2004

FDA approves revised labeling for anti-inflammatory corticosteroid nasal spray

AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).

26 Aug 2004

Cleaning products and solvents increase risk of asthma

Exposure to the fumes emitted from solvents and cleaning products at home may increase the risk of childhood asthma, suggests a study by Australian researchers from Curtin University and the University of Sydney.

25 Aug 2004

Effect of prebiotic and probiotic foods on health

A group of researchers at the Public University of Navarre, led by Senior Lecturer in Zoology, Elena Urdaneta Artola, have studied both the mechanisms whereby foodstuffs known as functional act at a gastrointestinal level as well as their possible beneficial effects on the health of individuals.

23 Aug 2004

Peginterferon and Ribavirin combination promising for those with HIV and HCV

Since the introduction of highly active combination drug therapy for HIV, liver failure attributable to infection with the hepatitis C virus (HCV) has become a leading cause of death among those infected with the virus that causes AIDS.

22 Aug 2004

Research will lead to better treatments for mastocytosis

Tens of millions of people know what it's like to suffer the seasonal torment of allergies, when just a whiff of pollen, mold or dust can set off a chain reaction in the body that causes sniffling, sneezing and coughing.

18 Aug 2004

Contract for the production of an investigational vaccine based on an H9N2 strain of avian influenza virus

In 1999 and 2003, an H9N2 influenza strain caused illness in three people in Hong Kong. Scientists are concerned about H9N2 and other emerging types of avian influenza viruses because as they spread—most commonly through poultry—they continually mutate, increasing chances that they may infect humans, evade the body’s immune response and become more lethal.

17 Aug 2004